PMC:7696151 / 32493-32695
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 910 | 170-178 | Species | denotes | patients | Tax:9606 |
| 963 | 105-108 | Chemical | denotes | HCQ | MESH:D006886 |
| 995 | 31-55 | Disease | denotes | QT-interval prolongation | MESH:D008133 |
| 996 | 179-187 | Disease | denotes | infected | MESH:D007239 |
| 997 | 193-201 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T219 | 0-202 | Sentence | denotes | ECG modification, resulting in QT-interval prolongation, is a characteristic side effect associated with HCQ treatment that has been shown in several clinical studies on patients infected with COVID-19. |